Leonard L. Mazur - Jul 22, 2021 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Jul 22, 2021
Transactions value $
$0
Form type
4
Date filed
7/26/2021, 05:02 PM
Next filing
Oct 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 10.3M Jul 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +300K $0.00 300K Jul 22, 2021 Common Stock 300K $2.00 Direct F7
holding CTXR Options to Purchase Common Stock 40K Jul 22, 2021 Common Stock 40K $3.45 Direct F1
holding CTXR Warrant to Purchase Common Stock 421K Jul 22, 2021 Common Stock 421K $4.13 Direct F2
holding CTXR Warrant to Purchase Common Stock 11K Jul 22, 2021 Common Stock 11K $4.13 Direct F2
holding CTXR Options to Purchase Common Stock 220K Jul 22, 2021 Common Stock 220K $6.75 Direct F3
holding CTXR Warrant to Purchase Common Stock 107K Jul 22, 2021 Common Stock 107K $4.63 Direct F2
holding CTXR Warrant to Purchase Common Stock 168K Jul 22, 2021 Common Stock 168K $2.86 Direct F2
holding CTXR Warrant to Purchase Common Stock 3.14M Jul 22, 2021 Common Stock 3.14M $1.15 Direct F2
holding CTXR Options to Purchase Common Stock 150K Jul 22, 2021 Common Stock 150K $1.62 Direct F4
holding CTXR Warrant to Purchase Common Stock 1.62M Jul 22, 2021 Common Stock 1.17M $1.42 Direct F2
holding CTXR Warrant to Purchase Common Stock 2.23M Jul 22, 2021 Common Stock 2.23M $0.77 Direct F2
holding CTXR Options to Purchase Common Stock 175K Jul 22, 2021 Common Stock 175K $0.67 Direct F5
holding CTXR Options to Purchase Common Stock 200K Jul 22, 2021 Common Stock 200K $1.01 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.
F2 The warrant is fully vested and exercisable immediately.
F3 The option vested as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017.
F4 One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.
F5 The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F6 The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F7 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.